Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Camidge, D. R.; Bang, Y.; Kwak, E. L.; Shaw, A. T.; Iafrate, A. J.; Maki, R. G.; Solomon, B. J.; Ou, S. I.; Salgia, R.; Wilner, K. D.; Costa, D. B.; Shapiro, G.; LoRusso, P.; Stephenson, P.; Tang, Y.; Ruffner, K.; Clark, J. W. |
| Abstract Title: | Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC) |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880301316 |
| DOI: | 10.1200/jco.2011.29.15_suppl.2501 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2501 -- Source: Wos |
